A pioneering clinical trial at Mayo Clinic’s Rochester Campus helped in treating Jared Ausnehmer who was born with hypoplastic left heart syndrome which affects around 1000 newborns in U.S. every year. The syndrome refers to a birth defect due to which left side of the heart is underdeveloped or non existent. Innovative clinical trial helped Jared return to athletic activities after a successful heart surgery.
Jared received several treatments for his heart condition, however by his early 20s, heart was enlarged and its neoaortic valve was leaking badly. Consequently, he ended up lying on the couch all day long. After watching the news, Jared’s mom, Patty tried to learn more about how Stem Cell could be used to treat her son’s heart syndrome.
In the course of her research, she consulted with Tim Nelson, M.D., Ph.D , a Mayo Clinic physician and researcher who mentioned that they were undertaking Stem Cell Therapy only for infants and not young adults. They learned from Mayo Clinic that Jared could participate in another study and receive care from Mayo Clinic doctors until a Stem Cell clinical trial for adults become available.
Jared’s condition had deteriorated by the time he came to Mayo Clinic in 2012. Over the next few weeks, pediatric cardiologist Patrick O’Leary, M.D. modified his medication to improve his health condition. With each medication adjustment, his condition improved almost immediately and he was able to return home where he received further treatment from local cardiologist in Ohio who was in constant touch with Mayo Clinic doctors.
The following year, follow up tests at Mayo Clinic showed improvement in percentage of blood leaving the heart, implying remarkable recovery from crippling heart failure to being an active adult. Dr. Nelson mentioned that he was trying to seek permission from FDA to use Stem Cells derived from bone marrow for young adults suffering from hypnoplastic syndrome. However, by spring of 2014 Jared was admitted to hospital since he was dehydrated and his kidneys were not working. Heart transplantation was the only option left in such circumstances but it was not good for him since past treatments made rejection of transplanted organ very likely.
In December 2015, Jared underwent a clinical trial wherein he was injected with Stem Cells from his bone marrow through a heart catheterisation. Yasir Qureshi, M.B.B.S., lead investigator for the clinical trial said that Jared gave a very remarkable response to Stem Cell Therapy. By August of 2016, Jared’s condition was strong enough to undergo an open heart surgery by Cardiothoracic surgeon Joseph Dearani, M.D., to replace his leaky valve and to place the pacemaker in his abdomen. Stem Cell Therapy offered him a new life including freedom to engage in athletic competitions.
United Access Medical offers its clients safe treatments for wide variety of diseases using Stem Cell and other Supportive Therapies. To learn more about the treatments, contact us and one of our Patient Representatives will call you back to answer your queries.
H/T: Mayo Clinic